부광약품

003000KOSPI의약품 제조업

55.8 / 100

Reference Date: 2026-07-24

Financial Score19.0 / 40

News Sentiment20.8 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Slightly down 1.6% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Bupyeong Pharmaceutical, established in 1960, is a pharmaceutical manufacturer and distributor specializing in products like Faloba and Dexid. In 2023, it achieved a profit turnaround with consolidated sales of 160.1 billion won and operating profit of 1.6 billion won, marking a 27% sales growth year-on-year.

Number of Employees

650people

Average Salary

62.7M KRW

Score Calculation Basis

Detailed Financial Score

PER

26.45Industry Average 11.230.0Point

2.4x industry avg (risky)

PBR

1.16Industry Average 0.812.5Point

Higher than industry avg (caution)

ROE

4.25Industry Average 4.014.0Point

In line with industry avg

Debt Ratio

5.15Industry Average 12.436.5Point

Half of industry avg (excellent)

Trend 2023~20256.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲26.3% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲439.9% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -3.6% (improving, 3yr)

Detailed News Sentiment

15 totalPositive 14Neutral 0Negative 1Average Sentiment Score 83.3

Positive
상반기 매출 1000억 첫 돌파...부광약품 ‘M&A’ 효과 톡톡
부광약품의 상반기 매출이 창사 이래 처음으로 1000억원을 돌파하며, 인수합병(M&A)을 통한 성장과 신약 개발로 긍정적인 성과를 보였다.
Positive
부광약품, 사상 첫 상반기 매출 1천억 원 돌파…"전문의약품 판매 호....
부광약품이 상반기 매출이 전년 대비 15.9% 증가하며 사상 첫 1천억 원을 돌파했다.
Positive
부광약품 ‘한국유니온제약 인수’ 효과 봤다…상반기 매출 1000억 첫...
부광약품의 인수합병으로 인해 상반기 매출이 전년 대비 크게 증가하며 긍정적인 성장을 보임.

Detailed Momentum

52-week position1.0Point

Near 52w low (12%, downtrend)

Current 4,020Won52-week high 9,60052-week low 3,225

1-month return3.0Point

1m -1.59% (flat)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral연결재무제표기준영업(잠정)실적(공정공시)2026-07-21
Neutral기업설명회(IR)개최(안내공시)2026-07-15